IGHA1 and neoplasm: Dissimilar to enriched pathways in CC1-derived mEPCs (e.g., tissue remodeling, neutrophil activation), mEPCs in GBC11 displayed ectopic expression of IGHA1 (Fig. 2g), presumably mediating aberrant tumor immunity and promoting tumor aggressiveness (Fig. 2h)21.